Graves’ disease is an autoimmune disorder in which thyroid-stimulating antibodies activate the thyroid’s TSH receptor, driving overproduction of thyroid hormone. It is the most common cause of hyperthyroidism in the United States, affecting roughly 1 in 200 people, with a strong female predominance and typical onset between about ages 30 and 50, according to the NIDDK. Untreated, it can produce serious cardiovascular complications including atrial fibrillation and heart failure, and the rare but life-threatening thyroid storm. The core treatment options have been stable for decades and remain effective, while care for the associated eye disease has advanced in recent years. This guide is educational and does not replace evaluation and management by your own clinicians.
The Autoimmune Mechanism
Graves’ is caused by thyroid-stimulating immunoglobulins (TSI), also called TSH receptor antibodies (TRAb), that bind and activate the TSH receptor on thyroid follicular cells. The result is unregulated, sustained stimulation that drives both excessive hormone production and gland enlargement (goiter). The same antibodies — and related immune mechanisms — can cross-react with tissues behind the eye, producing the distinctive Graves’ eye disease (ophthalmopathy or thyroid eye disease).
Genetic susceptibility plays a major role, and family history is common. Recognized triggers include stress, smoking, the postpartum period, infection, and possibly excess iodine intake.
Hyperthyroid Symptoms
Symptoms reflect a hypermetabolic state. Unintended weight loss despite a normal or increased appetite is classic, though a meaningful minority of patients — particularly older ones — gain weight instead. Heat intolerance, sweating, palpitations, tremor, anxiety, irritability, and insomnia are common. Frequent loose stools, muscle weakness (especially in the thighs and shoulders), and menstrual changes also occur.
Cardiovascular symptoms can dominate, especially in older patients. Atrial fibrillation affects a notable share of hyperthyroid patients over 60. Resting tachycardia and exercise intolerance are nearly universal. As the Cleveland Clinic notes, untreated severe hyperthyroidism can produce heart failure even in younger patients.
Graves’ Eye Disease (Ophthalmopathy)
Eye involvement affects a substantial fraction of patients to some degree, with severe disease in a small minority. Symptoms include eyelid retraction, a prominent-eye appearance (proptosis), irritation, dryness, double vision, and, in severe cases, optic nerve compromise that can threaten vision.
Smoking dramatically worsens eye disease and is the single most modifiable risk factor. Radioactive iodine therapy can transiently worsen eye disease, particularly in smokers; short courses of corticosteroids around the time of treatment may be used in patients with active eye disease. Teprotumumab, an IGF-1 receptor antagonist, was FDA-approved in 2020 for active moderate-to-severe thyroid eye disease and produces meaningful improvements in proptosis and double vision in trials. It is notably expensive — a full infusion course has been reported to cost in the range of hundreds of thousands of dollars — and actual price and insurance coverage vary, so verify current figures with the manufacturer and your insurer.
Diagnosis
TSH is suppressed (often below 0.1 mIU/L) in overt hyperthyroidism, while free T4 and free T3 are elevated. Subclinical hyperthyroidism shows a suppressed TSH with normal free T4 and free T3. TRAb is positive in the large majority of Graves’ patients and is the most specific blood test for the diagnosis.
A radioactive iodine uptake (RAIU) scan can distinguish Graves’ (high, diffuse uptake) from toxic nodular goiter (high, nodular uptake), thyroiditis (low uptake), and exogenous thyroid hormone use (low uptake). RAIU is not always needed when TRAb is clearly positive in a typical clinical picture. Thyroid ultrasound with Doppler is an alternative in some settings, including pregnancy, where radioactive tracers are avoided.
Three Main Treatment Options
Treatment is individualized with an endocrinologist. The descriptions below outline how each option works; they intentionally do not include specific drug doses, which your prescriber sets and adjusts based on your labs.
Antithyroid drugs — methimazole or propylthiouracil (PTU) — block thyroid hormone synthesis. Methimazole is preferred for most patients because of convenient dosing, generally lower liver toxicity, and good remission rates. PTU is generally reserved for the first trimester of pregnancy (methimazole carries a small but real risk of birth defects in early pregnancy) and for thyroid storm. A meaningful share of patients — commonly cited as roughly a third to 40 percent — achieve durable remission after 12 to 18 months of therapy. Predictors of remission include a smaller goiter, lower TRAb levels, and milder initial disease.
Both antithyroid drugs carry important warnings. Rash is relatively common. Agranulocytosis (a dangerous drop in white blood cells) is rare but serious — patients are told to stop the drug and get an urgent blood count if they develop fever or sore throat. Both drugs can also cause liver injury, and PTU in particular carries a boxed warning for severe liver toxicity. Report jaundice, dark urine, or right-upper-abdominal pain promptly.
Radioactive iodine (I-131) destroys overactive thyroid tissue gradually over weeks to months. It is a common definitive treatment for non-pregnant adults in the US. Most patients become hypothyroid within 6 to 12 months and then require lifelong levothyroxine. Pregnancy must be deferred for a period after treatment (commonly at least 6 months), and it is not used during pregnancy or breastfeeding. Active eye disease may worsen, which can sometimes be mitigated with corticosteroid coverage.
Total or near-total thyroidectomy is the third option. It offers immediate control and is preferred for very large goiters, suspected malignancy in a nodule, severe eye disease, or certain pregnancy situations. Surgical risks include injury to the recurrent laryngeal nerve (affecting the voice) and hypoparathyroidism (low calcium). Lifelong levothyroxine is required afterward.
| Option | How it works | Key considerations |
|---|---|---|
| Antithyroid drugs | Block hormone synthesis | Possible remission; watch for rash, agranulocytosis, liver injury |
| Radioactive iodine | Gradually destroys thyroid tissue | Usually leads to lifelong hypothyroidism; avoid in pregnancy; may worsen eye disease |
| Surgery (thyroidectomy) | Removes the thyroid | Immediate control; nerve and parathyroid risks; lifelong levothyroxine |
Beta-Blockers for Symptom Control
Beta-blockers such as propranolol or atenolol help control tachycardia, palpitations, tremor, and anxiety while definitive treatment takes effect. They do not lower thyroid hormone levels but blunt its peripheral effects. They are often started at diagnosis and tapered as thyroid function normalizes, under a clinician’s direction.
When to seek emergency care: Call 911 or go to the nearest emergency room for high fever with heavy sweating and confusion (possible thyroid storm), severe palpitations with chest pain or fainting, severe shortness of breath, sudden vision loss or severe eye pain (possible optic nerve compromise in Graves’ eye disease), or severe agitation. Also seek prompt evaluation for fever and sore throat while taking methimazole or PTU (possible agranulocytosis — stop the drug and get an urgent blood count). Thyroid storm is a medical emergency with substantial mortality even when treated.
Thyroid Storm
Thyroid storm is the extreme end of hyperthyroidism — typically triggered by infection, surgery, trauma, or abrupt withdrawal of antithyroid drugs in someone with poorly controlled Graves’. Features include high fever (often above 103°F), a racing heart, atrial fibrillation, heart failure, severe agitation or delirium, vomiting, and diarrhea. Mortality remains significant even with optimal intensive care.
Treatment combines antithyroid drugs, beta-blockers, corticosteroids, iodine (given after antithyroid drugs are on board), supportive care, and treatment of the precipitating illness — all in a hospital. Rapid recognition matters, because outcomes worsen with delay.
Pregnancy and Graves’ Disease
Hyperthyroidism in pregnancy raises the risk of miscarriage, preterm birth, preeclampsia, low birth weight, and, rarely, fetal or neonatal hyperthyroidism from maternal antibodies crossing the placenta. PTU is generally preferred in the first trimester because of methimazole’s small teratogenic risk; many clinicians switch to methimazole in the second and third trimesters given PTU’s liver risk. Treatment aims to keep free T4 in the upper-normal range using the lowest effective dose, set by the care team.
Measuring TRAb levels in the second trimester helps estimate fetal risk. High maternal TRAb can produce neonatal hyperthyroidism needing treatment after birth, even if the mother is currently hypothyroid after thyroidectomy. Coordination between endocrinology and high-risk obstetrics is standard.
Living With Graves’ Disease
Smoking cessation is the single most important lifestyle intervention; it reduces eye-disease severity and progression. Iodine intake should be reasonable but not excessive — kelp supplements and very high-iodine foods are generally avoided. Adequate sleep, stress management, and keeping follow-up appointments all support good control.
Most patients return to normal life within months of effective treatment. Patients on antithyroid drugs need periodic TSH and thyroid-hormone checks during dose adjustment, then less frequently once stable. Patients treated with radioactive iodine or surgery need lifelong levothyroxine and periodic TSH monitoring. Our medical conditions overview covers chronic-disease management broadly, and our Hashimoto’s guide covers the opposite autoimmune thyroid condition, which can occasionally develop after Graves’ treatment.
When to See a Doctor
Unexplained weight loss, palpitations, heat intolerance, tremor, anxiety, or new eye prominence warrant TSH testing. Established Graves’ patients should seek prompt evaluation for new fever and sore throat (possible agranulocytosis), worsening eye symptoms, severe palpitations, or pregnancy. Endocrinology referral is standard for treatment decisions, and ophthalmology should be involved for any active eye disease.
Frequently Asked Questions
Is Graves’ disease life-threatening?
Most cases are not, with effective treatment. Rare but serious complications include thyroid storm, severe arrhythmias, and compressive optic neuropathy. Untreated severe hyperthyroidism over time can cause heart failure. With modern care, most patients have excellent outcomes.
Can Graves’ disease be cured?
Definitive treatments — radioactive iodine and total thyroidectomy — eliminate hyperthyroidism but usually produce hypothyroidism requiring lifelong levothyroxine. Antithyroid drugs produce sustained remission in a substantial minority of patients after 12 to 18 months. Long-term remission off all therapy is possible but not guaranteed.
Will I need to take levothyroxine forever?
If treated with radioactive iodine or thyroidectomy, almost certainly yes. If treated with antithyroid drugs and you achieve remission, you may not need levothyroxine unless hyperthyroidism returns or hypothyroidism develops, which happens in some patients over time.
Can stress cause Graves’ disease?
Stress does not directly cause Graves’ but is recognized as a possible trigger in genetically predisposed people, particularly major life stressors. The postpartum period is a known higher-risk window. Managing stress is reasonable but is not a substitute for definitive treatment.
What is the difference between Graves’ disease and hyperthyroidism?
Hyperthyroidism is the general state of having too much thyroid hormone; it has several causes. Graves’ disease is one specific, autoimmune cause of hyperthyroidism — and the most common one. Identifying the underlying cause, often with TRAb testing and sometimes a scan, guides the right treatment.
TL;DR
- Graves’ disease is autoimmune hyperthyroidism and the most common cause of an overactive thyroid.
- Diagnosis: suppressed TSH with elevated thyroid hormones, positive TRAb, sometimes a radioactive iodine uptake scan.
- Three treatments — antithyroid drugs, radioactive iodine, and surgery — each with tradeoffs, chosen with an endocrinologist.
- Emergencies: thyroid storm (high fever, racing heart, confusion) and fever with sore throat on antithyroid drugs (possible agranulocytosis).
- Stop smoking, especially with eye disease, and keep up with lab monitoring; most people do well with treatment.
This article is general education, not medical advice. Diagnosis and treatment of Graves’ disease should be directed by your clinicians. For a medical emergency in the US, call 911.
The Bottom Line
Graves’ disease is treatable with three time-tested options — antithyroid drugs, radioactive iodine, and thyroidectomy — each with distinct tradeoffs. The choice depends on disease severity, eye involvement, pregnancy plans, patient preference, and local expertise. Smoking cessation matters more than many patients realize, particularly with eye involvement. Recognizing thyroid storm and agranulocytosis as emergencies, monitoring carefully in pregnancy, and partnering with endocrinology for long-term management produce the best outcomes. Most patients live full, normal lives after effective treatment, though many need lifelong attention to thyroid status.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH) — Graves’ disease.
- American Thyroid Association (ATA) — guidelines for the diagnosis and management of hyperthyroidism.
- Mayo Clinic and Cleveland Clinic — Graves’ disease overviews.
- FDA / DailyMed — methimazole and propylthiouracil (PTU) prescribing information, including the PTU boxed warning; FDA approval of teprotumumab (Tepezza).
- Peer-reviewed reviews of thyroid storm diagnosis and management.